Loading...

Nicholas Fidelman, MD

Title(s)Professor, Radiology
SchoolSchool of Medicine
Address505 Parnassus Avenue
San Francisco CA 94117
Phone415-353-1300
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California, San FranciscoM.D.2002 Medicine
    Collapse Awards and Honors
    American Heart Association1999Research Fellowship

    Collapse Overview 
    Collapse Overview
    Nicholas Fidelman, MD, is an Associate Professor of Clinical Radiology at the University of California, San Francisco and UCSF Mount Zion. Dr. Fidelman received his medical degree from UCSF in 2002, and completed his residency in Diagnostic Radiology from UCSF in 2007, followed by a fellowship in Interventional Radiology from UCSF in 2008.

    Dr. Fidelman’s research interest is focused on determining the outcomes of many commonly performed procedures in Interventional Radiology, and on improving the safety and efficacy of imaging-guided interventions. One of Dr. Fidelman’s interventional oncology projects currently focuses on Yttrium-90 liver radioembolization in patients with primary and secondary liver malignancies and on safety of chemoembolization in patients with primary liver cancer and marginal liver reserve.

    Other ongoing projects are focused on biliary procedures, elucidating the role of percutaneous cholangiography and biliary drainage in management of patients with biliary complications after living-related liver transplantation, and determining optimal treatment for patients with malignant hilar bile duct obstruction. Dr. Fidelman has over 30 research publications, including comparative and evaluation studies.

    Expertise:
    Interventional Radiology

    Specialty:
    Angiography, interventional oncology, liver and bile ducts, hepatocellular carcinoma, chemoembolization, radioembolization

    Professional Interests:
    Radioembolization, chemoembolization, radiofrequency ablation, biliary interventions, genitourinary interventions, gynecologic interventions, and uterine fibroid embolization

    Education and Training:
    • Medical School: University of California, San Francisco
    • Internship: St. Mary’s Medical Center, San Francisco - Internal Medicine
    • Residency: University of California, San Francisco - Diagnostic Radiology
    • Fellowship: University of California, San Francisco - Interventional Radiology
    • Diplomat of the American Board of Radiology
    • Certificate of Additional Qualification in Vascular and Interventional Radiology

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Websites
    Collapse Featured Videos

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Intra-arterial Peptide Receptor Radionuclide Therapy using 90Y DOTATOC for Hepatic Metastases of Neuroendocrine Tumors. J Nucl Med. 2020 Jun 08. Lawhn-Heath C, Fidelman N, Chee B, Jivan S, Armstrong E, Zhang L, Lindsay S, Bergsland EK, Hope TA. PMID: 32513903.
      View in: PubMed   Mentions:    Fields:    
    2. Intermediate to Long-Term Clinical Outcomes of Percutaneous Cryoablation for Renal Masses. J Vasc Interv Radiol. 2020 Aug; 31(8):1242-1248. Knox J, Kohlbrenner R, Kolli K, Fidelman N, Kohi MP, Lehrman E, Lokken RP, Zagoria R, Kerlan RK, LaBerge J, Taylor AG. PMID: 32522505.
      View in: PubMed   Mentions:    Fields:    
    3. ACR Appropriateness Criteria® Radiologic Management of Iliofemoral Venous Thrombosis. J Am Coll Radiol. 2020 May; 17(5S):S255-S264. Farsad K, Kapoor BS, Fidelman N, Cain TR, Caplin DM, Eldrup-Jorgensen J, Gupta A, Higgins M, Hohenwalter EJ, Lee MH, McBride JJ, Minocha J, Rochon PJ, Sutphin PD, Lorenz JM. PMID: 32370969.
      View in: PubMed   Mentions:    Fields:    
    4. Holmium-166 radioembolisation after peptide receptor radionuclide therapy: much needed data to help inform future research. Lancet Oncol. 2020 04; 21(4):478-479. Fidelman N. PMID: 32112735.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    5. NANETS/SNMMI Consensus Statement on Patient Selection and Appropriate Use of 177Lu-DOTATATE Peptide Receptor Radionuclide Therapy. J Nucl Med. 2020 02; 61(2):222-227. Hope TA, Bodei L, Chan JA, El-Haddad G, Fidelman N, Kunz PL, Mailman J, Menda Y, Metz DC, Mittra ES, Pryma DA, Reidy-Lagunes DL, Singh S, Strosberg JR. PMID: 32015164.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    6. Endoscopic Magnetic Compression Anastomosis For Small Bowel Bypass in a High Operative Risk Setting. Surg Laparosc Endosc Percutan Tech. 2019 Oct; 29(5):e84-e87. Lebares CC, Graves CE, Lin MY, Fidelman N, Cello J, Harrison MR, Rogers S. PMID: 31107851.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    7. Prospective Phase II trial of drug-eluting bead chemoembolization for liver transplant candidates with hepatocellular carcinoma and marginal hepatic reserve. J Hepatocell Carcinoma. 2019; 6:93-103. Fidelman N, Johanson C, Kohi MP, Kolli KP, Kohlbrenner RM, Lehrman ED, Taylor AG, Kelley RK, Yao FY, Roberts JP, Kerlan RK. PMID: 31355158.
      View in: PubMed   Mentions:
    8. ACR Appropriateness Criteria® Radiologic Management of Venous Thromboembolism-Inferior Vena Cava Filters. J Am Coll Radiol. 2019 May; 16(5S):S214-S226. Minocha J, Smith AM, Kapoor BS, Fidelman N, Cain TR, Caplin DM, Eldrup-Jorgensen J, Farsad K, Gupta A, Lee MH, McBride JJ, Moores LK, Rochon PJ, Lorenz JM. PMID: 31054748.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    9. Outcomes after Peripancreatic Fluid Drainage in Patients with Simultaneous Pancreas-Kidney Transplantation. J Vasc Interv Radiol. 2019 Jun; 30(6):918-921. Knox J, Watson E, Fidelman N, Taylor AG, Kolli K, Lehrman E, Kohlbrenner R, Kohi MP. PMID: 30982638.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    10. Periprocedural Management of Patients Undergoing Liver Resection or Embolotherapy for Neuroendocrine Tumor Metastases. Pancreas. 2019 04; 48(4):496-503. Kwon DH, Paciorek A, Mulvey CK, Chan H, Fidelman N, Meng L, Nakakura EK, Zhang L, Bergsland EK, Van Loon K. PMID: 30946246.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    11. Safety and Efficacy of Transjugular Liver Biopsy in Patients with Left Lobe-Only Liver Transplants. J Vasc Interv Radiol. 2019 Jul; 30(7):1043-1047. Lee KA, Taylor A, Bartolome B, Fidelman N, Kolli KP, Kohi M, Kohlbrenner R, Laberge J, Lehrman E, Kerlan R. PMID: 30772167.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    12. Operator Dose Reduction during Transjugular Liver Biopsy Using a Radiation-Attenuating Drape: A Prospective, Randomized Study. J Vasc Interv Radiol. 2018 09; 29(9):1248-1253. Kohlbrenner R, Lehrman ED, Taylor AG, Kohi MP, Fidelman N, Kumar V, Conrad M, Kolli KP. PMID: 30061059.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    13. 90Y Radioembolization for Hepatic Malignancy in Patients with Previous Biliary Intervention: Multicenter Analysis of Hepatobiliary Infections. Radiology. 2018 Sep; 288(3):774-781. Devulapalli KK, Fidelman N, Soulen MC, Miller M, Johnson MS, Addo E, El-Haddad G, Nutting C, Morrison J, Farsad K, Lokken RP, Gaba RC, Fleming J, Brown DB, Kwan SW, Rose SC, Pennycooke KA, Liu DM, White SB, Gandhi R, Lazar AA, Kerlan RK. PMID: 29737954.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    14. ACR Appropriateness Criteria® Radiologic Management of Mesenteric Ischemia. J Am Coll Radiol. 2017 May; 14(5S):S266-S271. Fidelman N, AbuRahma AF, Cash BD, Kapoor BS, Knuttinen MG, Minocha J, Rochon PJ, Shaw CM, Ray CE, Lorenz JM. PMID: 28473083.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    15. Radiation Dose Reduction during Uterine Fibroid Embolization Using an Optimized Imaging Platform. J Vasc Interv Radiol. 2017 Aug; 28(8):1129-1135.e1. Kohlbrenner R, Kolli KP, Taylor AG, Kohi MP, Lehrman ED, Fidelman N, Conrad M, LaBerge JM, Kerlan RK, Gould R. PMID: 28457758.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    16. Letters to the Editor. J Vasc Interv Radiol. 2016 12; 27(12):1938-1939. Peter Lokken R, Fidelman N, Pallav Kolli K, Kerlan RK. PMID: 27886963.
      View in: PubMed   Mentions:    Fields:    
    17. Catheter directed interventions for acute deep vein thrombosis. Cardiovasc Diagn Ther. 2016 Dec; 6(6):599-611. Kohi MP, Kohlbrenner R, Kolli KP, Lehrman E, Taylor AG, Fidelman N. PMID: 28123980.
      View in: PubMed   Mentions:
    18. Radioembolization with 90Y glass microspheres for the treatment of unresectable metastatic liver disease from chemotherapy-refractory gastrointestinal cancers: final report of a prospective pilot study. J Gastrointest Oncol. 2016 Dec; 7(6):860-874. Fidelman N, Kerlan RK, Hawkins RA, Pampaloni M, Taylor AG, Kohi MP, Kolli KP, Atreya CE, Bergsland EK, Kelley RK, Ko AH, Korn WM, Van Loon K, McWhirter RM, Luan J, Johanson C, Venook AP. PMID: 28078110.
      View in: PubMed   Mentions:
    19. Imaging prediction of residual hepatocellular carcinoma after locoregional therapy in patients undergoing liver transplantation or partial hepatectomy. Abdom Radiol (NY). 2016 11; 41(11):2161-2168. Ehman EC, Umetsu SE, Ohliger MA, Fidelman N, Ferrell LD, Yeh BM, Yee J, Hope TA. PMID: 27484789.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    20. Embolotherapy for Neuroendocrine Tumor Liver Metastases: Prognostic Factors for Hepatic Progression-Free Survival and Overall Survival. Cardiovasc Intervent Radiol. 2017 Jan; 40(1):69-80. Chen JX, Rose S, White SB, El-Haddad G, Fidelman N, Yarmohammadi H, Hwang W, Sze DY, Kothary N, Stashek K, Wileyto EP, Salem R, Metz DC, Soulen MC. PMID: 27738818.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    21. Safety and Efficacy of Doxorubicin Drug-Eluting Embolic Chemoembolization of Hepatocellular Carcinoma Supplied by Extrahepatic Collateral Arteries. J Vasc Interv Radiol. 2016 Nov; 27(11):1698-1704. Lokken RP, Fidelman N, Kolli KP, Kerlan RK. PMID: 27397617.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    22. Rate of observation and inter-observer agreement for LI-RADS major features at CT and MRI in 184 pathology proven hepatocellular carcinomas. Abdom Radiol (NY). 2016 05; 41(5):963-9. Ehman EC, Behr SC, Umetsu SE, Fidelman N, Yeh BM, Ferrell LD, Hope TA. PMID: 27193793.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    23. Intention to treat outcome of T1 hepatocellular carcinoma with the "wait and not ablate" approach until meeting T2 criteria for liver transplant listing. Liver Transpl. 2016 Feb; 22(2):178-87. Mehta N, Sarkar M, Dodge JL, Fidelman N, Roberts JP, Yao FY. PMID: 26479422.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    24. Reassessing the boundaries of liver transplantation for hepatocellular carcinoma: Where do we stand with tumor down-staging? Hepatology. 2016 Mar; 63(3):1014-25. Yao FY, Fidelman N. PMID: 26560491.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    25. Transarterial Chemoembolization and (90)Y Radioembolization for Hepatocellular Carcinoma: Review of Current Applications Beyond Intermediate-Stage Disease. AJR Am J Roentgenol. 2015 Oct; 205(4):742-52. Fidelman N, Kerlan RK. PMID: 26397322.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    26. Periprocedural Patient Care. Radiographics. 2015 Oct; 35(6):1766-78. Kohi MP, Fidelman N, Behr S, Taylor AG, Kolli K, Conrad M, Hwang G, Weinstein S. PMID: 26466184.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    27. Retained Placenta Accreta Mimicking Choriocarcinoma. Case Rep Pathol. 2015; 2015:167986. Kohi MP, Rizzuto GA, Fidelman N, Lucero J, Thiet MP. PMID: 26495146.
      View in: PubMed   Mentions:
    28. Imaging Predictors of Elevated Lung Shunt Fraction in Patients Being Considered for Yttrium-90 Radioembolization. J Vasc Interv Radiol. 2015 Oct; 26(10):1472-8. Olorunsola OG, Kohi MP, Behr SC, Kolli PK, Taylor AG, Tong RT, LaBerge JM, Kerlan RK, Fidelman N. PMID: 26296737.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCellsCTClinical Trials
    29. Patient Radiation Dose Reduction during Transarterial Chemoembolization Using a Novel X-Ray Imaging Platform. J Vasc Interv Radiol. 2015 Sep; 26(9):1331-8. Kohlbrenner R, Kolli KP, Taylor AG, Kohi MP, Fidelman N, LaBerge JM, Kerlan RK, Agarwal VK, Lehrman ED, Nanavati S, Avrin DE, Gould R. PMID: 26212556.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    30. Crossed legs: an unexpected occurrence during an ALN filter placement. Clin Imaging. 2015 Nov-Dec; 39(6):1128-9. Kohi MP, Taylor AG, Kolli KP, Fidelman N, Kerlan RK. PMID: 26253773.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    31. Benign Biliary Strictures: Diagnostic Evaluation and Approaches to Percutaneous Treatment. Tech Vasc Interv Radiol. 2015 Dec; 18(4):210-7. Fidelman N. PMID: 26615161.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    32. Hemothorax resulting from injury to the right inferior phrenic artery following transhepatic procedures. J Vasc Interv Radiol. 2015 Apr; 26(4):600-1. Bartolome B, Kohi MP, Fidelman N, Taylor AG, Kolli KP, LaBerge JM, Kerlan RK. PMID: 25805544.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    33. Implications of discordant findings between hepatic angiography and cross-sectional imaging in transplant candidates with hepatocellular carcinoma. Liver Transpl. 2015 Apr; 21(4):454-67. Young K, Fidelman N, Yao FY, Hills NK, Kohi MP, Kolli KP, Taylor AG, Kerlan RK. PMID: 25678220.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    34. Downstaging of hepatocellular cancer before liver transplant: long-term outcome compared to tumors within Milan criteria. Hepatology. 2015 Jun; 61(6):1968-77. Yao FY, Mehta N, Flemming J, Dodge J, Hameed B, Fix O, Hirose R, Fidelman N, Kerlan RK, Roberts JP. PMID: 25689978.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    35. Hepatic artery and biliary complications in liver transplant recipients undergoing pretransplant transarterial chemoembolization. Liver Transpl. 2014 Oct; 20(10):1221-8. Goel A, Mehta N, Guy J, Fidelman N, Yao F, Roberts J, Terrault N. PMID: 25045002.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    36. Hook, line, and sinker: hook wire localization of a retained suture needle in the perineum. J Vasc Interv Radiol. 2014 Sep; 25(9):1479-80. Kohi MP, Naeger DM, Lorenson MJ, Taylor AG, Kolli KP, Fidelman N, Kerlan RK. PMID: 25150906.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    37. 90Y glass microspheres for the treatment of unresectable metastatic liver disease from chemotherapy-refractory gastrointestinal cancers: a pilot study. J Gastrointest Cancer. 2014 Jun; 45(2):168-80. Fidelman N, Kerlan RK, Hawkins RA, Taylor AG, Kohi MP, Kolli KP, Bergsland EK, Kelley RK, Ko AH, Korn WM, McWhirter RM, Luan J, Venook AP. PMID: 24448917.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    38. The inferior emissary vein: a reliable landmark for right adrenal vein sampling. Acta Radiol. 2015 Apr; 56(4):454-7. Kohi MP, Agarwal VK, Naeger DM, Taylor AG, Kolli KP, Fidelman N, LaBerge JM, Kerlan RK. PMID: 24682403.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    39. Percutaneous interventions in failing "necklace" hemodialysis grafts: long-term outcomes. J Vasc Interv Radiol. 2014 Feb; 25(2):199-205. Price AJ, Fidelman N, Wilson MW, Kerlan RK. PMID: 24290096.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    40. Efficacy of TACE in TIPS patients: comparison of treatment response to chemoembolization for hepatocellular carcinoma in patients with and without a transjugular intrahepatic portosystemic shunt. Cardiovasc Intervent Radiol. 2013 Oct; 36(5):1336-43. Kuo YC, Kohi MP, Naeger DM, Tong RT, Kolli KP, Taylor AG, Laberge JM, Kerlan RK, Fidelman N. PMID: 23864021.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    41. Outcomes of metallic biliary stent insertion in patients with malignant bilobar obstruction. J Vasc Interv Radiol. 2013 Jul; 24(7):1003-10. Veal DR, Lee AY, Kerlan RK, Gordon RL, Fidelman N. PMID: 23796087.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    42. Distribution of reported StarClose SE vascular closure device complications in the manufacturer and user facility device experience database. J Vasc Interv Radiol. 2013 Jul; 24(7):1051-6. Johnson DT, Durack JC, Fidelman N, Kerlan RK, LaBerge JM. PMID: 23796092.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    43. Failure of filter reexpansion during unsuccessful retrieval of Option inferior vena cava filter. J Vasc Interv Radiol. 2013 Jul; 24(7):1065-7. Olorunsola OG, Kohi MP, Fidelman N, LaBerge JM, Kerlan RK. PMID: 23796095.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    44. Reply to Re: Hepatotoxicity after transarterial chemoembolization and transjugular intrahepatic portosystemic shunt: do two rights make a wrong? J Vasc Interv Radiol. 2013 Jul; 24(7):1076. Kohi MP, Fidelman N, Kerlan RK. PMID: 23796101.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    45. Clinical outcomes of percutaneous drainage of breast fluid collections after mastectomy with expander-based breast reconstruction. J Vasc Interv Radiol. 2013 Sep; 24(9):1369-74. Tong RT, Kohi M, Fidelman N, Kuo YC, Foster R, Peled A, Kolli KP, Taylor AG, LaBerge JM, Kerlan RK. PMID: 23810309.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    46. ACR Appropriateness Criteria radiologic management of benign and malignant biliary obstruction. J Am Coll Radiol. 2013 Aug; 10(8):567-74. Ray CE, Lorenz JM, Burke CT, Darcy MD, Fidelman N, Greene FL, Hohenwalter EJ, Kinney TB, Kolbeck KJ, Kostelic JK, Kouri BE, Nair AV, Owens CA, Rochon PJ, Rockey DC, Vatakencherry G. PMID: 23763879.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    47. Preoperative CT-Guided percutaneous wire localization of ground glass pulmonary nodules with a modified Kopans wire. J Thorac Dis. 2013 Apr; 5(2):E31-4. Kohi MP, Naeger DM, Kukreja J, Fidelman N, Laberge JM, Gordon RL, Kerlan RK. PMID: 23585953.
      View in: PubMed   Mentions:
    48. Caval penetration by retrievable inferior vena cava filters: a retrospective comparison of Option and Günther Tulip filters. J Vasc Interv Radiol. 2013 Apr; 24(4):566-71. Olorunsola OG, Kohi MP, Fidelman N, Westphalen AC, Kolli PK, Taylor AG, Gordon RL, LaBerge JM, Kerlan RK. PMID: 23462065.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    49. Management of well-differentiated gastrointestinal neuroendocrine tumors metastatic to the liver. Semin Oncol. 2013 Feb; 40(1):69-74. Wang SC, Fidelman N, Nakakura EK. PMID: 23391114.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    50. Factors associated with outcomes and response to therapy in patients with infiltrative hepatocellular carcinoma. Clin Gastroenterol Hepatol. 2013 May; 11(5):572-8. Mehta N, Fidelman N, Sarkar M, Yao FY. PMID: 23333661.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    51. Morbidity and mortality following transarterial liver chemoembolization in patients with hepatocellular carcinoma and synthetic hepatic dysfunction. Liver Transpl. 2013 Feb; 19(2):164-73. Garwood ER, Fidelman N, Hoch SE, Kerlan RK, Yao FY. PMID: 23008091.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    52. Transcatheter arterial embolization for upper gastrointestinal nonvariceal hemorrhage: is empiric embolization warranted? Cardiovasc Intervent Radiol. 2012 Dec; 35(6):1346-54. Arrayeh E, Fidelman N, Gordon RL, LaBerge JM, Kerlan RK, Klimov A, Bloom AI. PMID: 22302348.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    53. ACR Appropriateness Criteria radiologic management of hepatic malignancy. J Am Coll Radiol. 2012 Dec; 9(12):919-25. Kouri BE, Funaki BS, Ray CE, Abou-Alfa GK, Burke CT, Darcy MD, Fidelman N, Greene FL, Harrison SA, Kinney TB, Kostelic JK, Lorenz JM, Nair AV, Nemcek AA, Owens CA, Saad WE, Vatakencherry G. PMID: 23206650.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    54. Hepatotoxicity after transarterial chemoembolization and transjugular intrahepatic portosystemic shunt: do two rights make a wrong? J Vasc Interv Radiol. 2013 Jan; 24(1):68-73. Kohi MP, Fidelman N, Naeger DM, LaBerge JM, Gordon RL, Kerlan RK. PMID: 23176968.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    55. Percutaneous transhepatic balloon dilation of biliary-enteric anastomotic strictures after surgical repair of iatrogenic bile duct injuries. PLoS One. 2012; 7(10):e46478. Lee AY, Gregorius J, Kerlan RK, Gordon RL, Fidelman N. PMID: 23110053.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    56. Pretransplant prediction of microvascular invasion in patients with hepatocellular carcinoma: added value of diffusion-weighted magnetic resonance imaging. Liver Transpl. 2012 Oct; 18(10):1131-3. Fidelman N, Qayyum A. PMID: 22899661.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    57. The transjugular intrahepatic portosystemic shunt: an update. AJR Am J Roentgenol. 2012 Oct; 199(4):746-55. Fidelman N, Kwan SW, LaBerge JM, Gordon RL, Ring EJ, Kerlan RK. PMID: 22997364.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    58. Imaging predictors of the response to transarterial chemoembolization in patients with hepatocellular carcinoma: a radiological-pathological correlation. Liver Transpl. 2012 Jun; 18(6):727-36. Kwan SW, Fidelman N, Ma E, Kerlan RK, Yao FY. PMID: 22344899.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    59. Reducing the rate of repeat imaging: import of outside images to PACS. AJR Am J Roentgenol. 2012 Mar; 198(3):628-34. Lu MT, Tellis WM, Fidelman N, Qayyum A, Avrin DE. PMID: 22358003.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    60. ACR appropriateness criteria® radiologic management of thoracic nodules and masses. J Am Coll Radiol. 2012 Jan; 9(1):13-9. Ray CE, English B, Funaki BS, Burke CT, Fidelman N, Ginsburg ME, Kinney TB, Kostelic JK, Kouri BE, Lorenz JM, Nair AV, Nemcek AA, Owens CA, Saleh AG, Vatakencherry G, Mohammed TL. PMID: 22221631.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    61. Entrapment of the StarClose Vascular Closure System after attempted common femoral artery deployment. Cardiovasc Intervent Radiol. 2012 Aug; 35(4):942-4. Durack JC, Thor Johnson D, Fidelman N, Kerlan RK, LaBerge JM. PMID: 21947552.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    62. Mixed hepatocellular cholangiocarcinoma and intrahepatic cholangiocarcinoma in patients undergoing transplantation for hepatocellular carcinoma. Liver Transpl. 2011 Aug; 17(8):934-42. Sapisochin G, Fidelman N, Roberts JP, Yao FY. PMID: 21438129.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    63. Transcatheter arterial embolization of spontaneous life-threatening extraperitoneal hemorrhage. J Vasc Interv Radiol. 2011 Oct; 22(10):1396-402. Farrelly C, Fidelman N, Durack JC, Hagiwara E, Kerlan RK. PMID: 21778068.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    64. Rex shunt preoperative imaging: diagnostic capability of imaging modalities. PLoS One. 2011; 6(7):e22222. Kwan SW, Fidelman N, Durack JC, Roberts JP, Kerlan RK. PMID: 21765956.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    65. Accuracy of percutaneous transhepatic cholangiography in predicting the location and nature of major bile duct injuries. J Vasc Interv Radiol. 2011 Jun; 22(6):884-92. Fidelman N, Kerlan RK, Laberge JM, Gordon RL. PMID: 21514840.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    66. Management of recurrent airway strictures in lung transplant recipients using AERO covered stents. J Vasc Interv Radiol. 2010 Dec; 21(12):1900-4. Tan JH, Fidelman N, Durack JC, Hays SR, Leard LL, Laberge JM, Kerlan RK, Golden JA, Gordon RL. PMID: 20970355.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    67. Complications associated with the percutaneous insertion of fiducial markers in the thorax. Cardiovasc Intervent Radiol. 2010 Dec; 33(6):1186-91. Bhagat N, Fidelman N, Durack JC, Collins J, Gordon RL, LaBerge JM, Kerlan RK. PMID: 20661565.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    68. Arterial embolization for the management of gastrointestinal hemorrhage from metastatic renal cell carcinoma. J Vasc Interv Radiol. 2010 May; 21(5):741-4. Fidelman N, Freed RC, Nakakura EK, Rosenberg J, Bloom AI. PMID: 20304675.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    69. Reperfusion of pulmonary arteriovenous malformations after successful embolotherapy with vascular plugs. J Vasc Interv Radiol. 2008 Aug; 19(8):1246-50. Fidelman N, Gordon RL, Bloom AI, LaBerge JM, Kerlan RK. PMID: 18656022.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    70. Hepatic arterial injuries after percutaneous biliary interventions in the era of laparoscopic surgery and liver transplantation: experience with 930 patients. Radiology. 2008 Jun; 247(3):880-6. Fidelman N, Bloom AI, Kerlan RK, Laberge JM, Wilson MW, Ring EJ, Gordon RL. PMID: 18487540.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    71. Percutaneous interventions in subclavian artery-to-contralateral subclavian vein "necklace" hemodialysis grafts: experience in five patients. J Vasc Interv Radiol. 2007 May; 18(5):597-601. Fidelman N, Allen D, Bloom AI, LaBerge JM, Hastings GS, Kerlan RK, Gordon RL, Wilson MW. PMID: 17494840.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    72. Orthopedic spinal and hip prostheses: effects of magnetic susceptibility artifacts during MR arteriography and venography of abdomen and pelvis. Radiology. 2006 Sep; 240(3):894-9. Fidelman NA, Wilson MW, Bloom AI, Kerlan RK, LaBerge JM, Gordon RL. PMID: 16926332.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    73. Postoperative evaluation of complex aortovisceral and aortorenal reconstructions by magnetic resonance angiography. Acad Radiol. 2004 Sep; 11(9):1055-8. Fidelman N, Wilson MW, Boddington S, Knoess N, Lutz J, Wolanske KA, Kerlan RK, Laberge JM, Gordon RL. PMID: 15350587.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    74. Hepatocellular carcinoma: regional therapy with a magnetic targeted carrier bound to doxorubicin in a dual MR imaging/ conventional angiography suite--initial experience with four patients. Radiology. 2004 Jan; 230(1):287-93. Wilson MW, Kerlan RK, Fidelman NA, Venook AP, LaBerge JM, Koda J, Gordon RL. PMID: 14695402.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    75. Experimental renal artery embolization in a combined MR imaging/angiographic unit. J Vasc Interv Radiol. 2003 Sep; 14(9 Pt 1):1169-75. Wilson MW, Fidelman N, Weber OM, Martin AJ, Gordon RL, LaBerge JM, Kerlan RK, Wolanske KA, Saeed M. PMID: 14514809.
      View in: PubMed   Mentions: 9     Fields:    Translation:Animals
    76. Evaluation of active bleeding into hematomas by technetium-99m red blood cell scintigraphy before angiography. Clin Nucl Med. 2002 Nov; 27(11):763-6. Wilson MW, Fidelman N, Lull RJ, Marder SR, Laberge JM, Kerlan RK, Gordon RL. PMID: 12394121.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    77. Real-time MR properties of particulate embolic agents tested in a dynamic flow model. J Vasc Interv Radiol. 2002 Jun; 13(6):613-8. Fidelman N, Wilson MW, Weber OM, Martin AJ, Kerlan RK, LaBerge JM, Gordon RL. PMID: 12050302.
      View in: PubMed   Mentions: 1     Fields:    
    78. Conditional expression of a Gi-coupled receptor causes ventricular conduction delay and a lethal cardiomyopathy. Proc Natl Acad Sci U S A. 2000 Apr 25; 97(9):4826-31. Redfern CH, Degtyarev MY, Kwa AT, Salomonis N, Cotte N, Nanevicz T, Fidelman N, Desai K, Vranizan K, Lee EK, Coward P, Shah N, Warrington JA, Fishman GI, Bernstein D, Baker AJ, Conklin BR. PMID: 10781088.
      View in: PubMed   Mentions: 35     Fields:    Translation:AnimalsCells
    79. Vector unpacking as a potential barrier for receptor-mediated polyplex gene delivery. Biotechnol Bioeng. 2000 Mar 05; 67(5):598-606. Schaffer DV, Fidelman NA, Dan N, Lauffenburger DA. PMID: 10649234.
      View in: PubMed   Mentions: 94     Fields:    Translation:Animals
    Nicholas's Networks
    Concepts (358)
    Derived automatically from this person's publications.
    _
    Co-Authors (64)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _